This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.
Federal Disaster Resources
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Missouri for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on February 16, 2021, detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Missouri and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Minnesota for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on February 10, 2021, indicated Minnesota’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maine for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on February 12, 2021 indicated Maine’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Louisiana for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 19, 2021 indicated Louisiana’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Idaho for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 7, 2021, indicated Idaho’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Iowa for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 12, 2021, indicated Iowa’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Florida for multiple section 1135 flexibilities on March 16, 2020. Your follow-up communication to CMS on February 9, 2021 indicated Florida’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Ohio for multiple section 1135 flexibilities on April 22, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Ohio’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maryland for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Maryland’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Delaware for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Delaware’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show
entries